Literature DB >> 21583693

3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.

Ahoya Anothane Caleb, Rachid Bouhfid, El Mokhtar Essassi, Lahcen El Ammari.   

Abstract

The title heterocyclic compound, C(14)H(15)N(3)O(3), is a new synthetic mol-ecule containing oxazolidine and quinoxaline rings. It is built up from two fused six-membered rings linked to a five-membered oxazolidin-2-one ring by a C(2) chain. Both ring systems are essentially planar [maximum deviation = 0.894 (3) Å, r.m.s. deviation = 0.0043 Å]. The structure is held together by van der Waals forces [electrostatic interactions between dipoles, O⋯C = 3.002 (2) Å] between mol-ecules and by weak π-π stacking between symmetry-related mol-ecules, with an inter-planar distance of 3.579 Å and a centroid-centroid distance of 3.800 (1) Å. Inter-molecular C-H⋯O hydrogen bonds are also observed in the crystal structure.

Entities:  

Year:  2009        PMID: 21583693      PMCID: PMC2977093          DOI: 10.1107/S1600536809028736

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of 3–2(-(3-methyl-2-oxoquinoxalin-1(2H)-yl) eth­yl)oxazolidin-2-one, see: Ferfra (2001 ▶); Habib & El-hawash (1997 ▶); Romer et al. (1995 ▶). For pharmaceutical agrochemicals, see: Badran et al. (2003 ▶); Madhusudhan et al. (2004 ▶); Soad et al. (2006 ▶); Sriharsha & Shashikanth (2006 ▶); Sarro et al. (2002 ▶). For a related structure, see: Doubia et al. (2007 ▶).

Experimental

Crystal data

C14H15N3O3 M = 273.29 Monoclinic, a = 12.280 (3) Å b = 10.736 (3) Å c = 20.406 (4) Å β = 102.32 (1)° V = 2628.3 (11) Å3 Z = 8 Mo Kα radiation μ = 0.10 mm−1 T = 298 K 0.28 × 0.17 × 0.12 mm

Data collection

Bruker X8 APEXII CCD area-detector diffractometer Absorption correction: none 21237 measured reflections 4108 independent reflections 2727 reflections with I > 2σ(I) R int = 0.033

Refinement

R[F 2 > 2σ(F 2)] = 0.050 wR(F 2) = 0.157 S = 1.04 4108 reflections 204 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.29 e Å−3 Δρmin = −0.24 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: SAINT (Bruker, 2005 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXS97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶) and PLATON (Spek, 2009 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536809028736/fj2233sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809028736/fj2233Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C14H15N3O3F(000) = 1152
Mr = 273.29Dx = 1.381 Mg m3
Monoclinic, C2/cMelting point: 448 K
Hall symbol: -C 2ycMo Kα radiation, λ = 0.71073 Å
a = 12.280 (3) ÅCell parameters from 21279 reflections
b = 10.736 (3) Åθ = 2.6–30.9°
c = 20.406 (4) ŵ = 0.10 mm1
β = 102.32 (1)°T = 298 K
V = 2628.3 (11) Å3Prism, colourless
Z = 80.28 × 0.17 × 0.12 mm
Bruker X8 APEXII CCD area-detector diffractometerRint = 0.033
graphiteθmax = 30.9°, θmin = 2.6°
φ and ω scansh = −17→17
21237 measured reflectionsk = −15→15
4108 independent reflectionsl = −26→29
2727 reflections with I > 2σ(I)
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.050Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.157H atoms treated by a mixture of independent and constrained refinement
S = 1.04w = 1/[σ2(Fo2) + (0.081P)2 + 0.6684P] where P = (Fo2 + 2Fc2)/3
4108 reflections(Δ/σ)max = 0.001
204 parametersΔρmax = 0.29 e Å3
0 restraintsΔρmin = −0.24 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.11176 (11)0.25753 (10)0.54216 (6)0.0630 (3)
O2−0.13309 (10)0.52714 (11)0.26113 (5)0.0598 (3)
O3−0.13793 (10)0.32026 (12)0.24503 (6)0.0662 (4)
N10.11384 (8)0.15986 (10)0.44405 (5)0.0353 (2)
N20.16192 (10)−0.06171 (10)0.51654 (5)0.0422 (3)
N3−0.06491 (10)0.40729 (10)0.34753 (5)0.0411 (3)
C10.12314 (11)0.16145 (12)0.51219 (6)0.0387 (3)
C20.14895 (11)0.04062 (12)0.54680 (6)0.0385 (3)
C30.15128 (10)−0.05948 (12)0.44748 (6)0.0375 (3)
C40.16612 (13)−0.17122 (14)0.41519 (8)0.0499 (4)
H40.1830 (15)−0.2426 (16)0.4433 (9)0.064 (5)*
C50.15685 (13)−0.17446 (16)0.34713 (8)0.0550 (4)
H50.0990 (14)0.1222 (17)0.3136 (8)0.061 (5)*
C60.13209 (13)−0.06520 (17)0.31028 (8)0.0524 (4)
H60.1300 (16)−0.0693 (17)0.2637 (11)0.070 (6)*
C70.11673 (12)0.04585 (15)0.34045 (7)0.0452 (3)
H70.1688 (16)−0.2533 (17)0.3259 (9)0.064 (5)*
C80.12719 (10)0.05051 (11)0.40996 (6)0.0341 (3)
C90.15977 (14)0.04223 (15)0.62100 (7)0.0522 (4)
H9A0.1775−0.04000.63860.090*
H9B0.09070.06900.63130.080*
H9C0.21810.09870.64090.071 (6)*
C100.08780 (11)0.27856 (12)0.40844 (7)0.0414 (3)
H10A0.12300.28110.37020.053 (4)*
H10B0.11710.34690.43810.047 (4)*
C11−0.03761 (11)0.29325 (13)0.38470 (7)0.0457 (3)
H11A−0.06700.22310.35650.062 (5)*
H11B−0.07230.29340.42320.069 (5)*
C12−0.0550 (2)0.52845 (15)0.37655 (9)0.0767 (6)
H12A0.02210.54850.39620.090*
H12B−0.09900.53610.41060.088*
C13−0.10029 (16)0.61022 (15)0.31685 (9)0.0625 (5)
H13A−0.16370.65780.32420.081 (6)*
H13B−0.04350.66760.30880.089 (7)*
C14−0.11293 (11)0.40817 (14)0.28215 (7)0.0429 (3)
U11U22U33U12U13U23
O10.0931 (9)0.0442 (6)0.0505 (6)0.0055 (6)0.0130 (6)−0.0100 (5)
O20.0708 (8)0.0578 (7)0.0454 (6)0.0030 (5)0.0000 (5)0.0146 (5)
O30.0708 (8)0.0718 (8)0.0502 (6)0.0112 (6)0.0005 (5)−0.0246 (6)
N10.0362 (5)0.0336 (5)0.0352 (5)0.0005 (4)0.0053 (4)0.0056 (4)
N20.0472 (6)0.0398 (6)0.0353 (6)−0.0030 (5)−0.0010 (4)0.0057 (4)
N30.0502 (7)0.0332 (5)0.0361 (6)0.0048 (4)0.0009 (5)0.0017 (4)
C10.0397 (6)0.0385 (6)0.0363 (6)−0.0027 (5)0.0048 (5)−0.0001 (5)
C20.0369 (6)0.0425 (7)0.0329 (6)−0.0078 (5)0.0005 (5)0.0033 (5)
C30.0360 (6)0.0370 (6)0.0368 (6)0.0008 (5)0.0016 (5)0.0028 (5)
C40.0525 (8)0.0400 (7)0.0528 (8)0.0061 (6)0.0013 (6)−0.0023 (6)
C50.0513 (9)0.0561 (9)0.0557 (9)0.0062 (7)0.0075 (7)−0.0160 (7)
C60.0475 (8)0.0734 (11)0.0373 (7)0.0010 (7)0.0110 (6)−0.0072 (7)
C70.0434 (7)0.0566 (8)0.0360 (7)0.0010 (6)0.0091 (5)0.0063 (6)
C80.0289 (6)0.0381 (6)0.0345 (6)0.0004 (4)0.0050 (4)0.0036 (5)
C90.0595 (9)0.0622 (9)0.0319 (6)−0.0168 (7)0.0030 (6)0.0035 (6)
C100.0425 (7)0.0341 (6)0.0463 (7)−0.0008 (5)0.0066 (5)0.0103 (5)
C110.0426 (7)0.0387 (7)0.0533 (8)0.0001 (5)0.0044 (6)0.0121 (6)
C120.1231 (18)0.0380 (8)0.0533 (10)0.0076 (9)−0.0162 (10)−0.0075 (7)
C130.0684 (11)0.0380 (8)0.0734 (11)0.0008 (7)−0.0019 (8)0.0086 (7)
C140.0399 (7)0.0513 (8)0.0368 (6)0.0074 (6)0.0067 (5)−0.0016 (6)
O1—C11.2223 (17)C5—H70.976 (19)
O2—C141.3532 (18)C6—C71.373 (2)
O2—C131.434 (2)C6—H60.95 (2)
O3—C141.2080 (18)C7—C81.3975 (18)
N1—C11.3708 (16)C7—H50.984 (18)
N1—C81.3921 (16)C9—H9A0.9600
N1—C101.4680 (16)C9—H9B0.9600
N2—C21.2868 (18)C9—H9C0.9600
N2—C31.3874 (17)C10—C111.5208 (19)
N3—C141.3387 (17)C10—H10A0.9700
N3—C121.4237 (19)C10—H10B0.9700
N3—C111.4415 (16)C11—H11A0.9700
C1—C21.4787 (18)C11—H11B0.9700
C2—C91.4915 (19)C12—C131.508 (2)
C3—C41.3991 (19)C12—H12A0.9700
C3—C81.4041 (17)C12—H12B0.9700
C4—C51.369 (2)C13—H13A0.9700
C4—H40.953 (17)C13—H13B0.9700
C5—C61.392 (2)
C14—O2—C13109.55 (11)C2—C9—H9B109.5
C1—N1—C8121.61 (10)H9A—C9—H9B109.5
C1—N1—C10116.97 (11)C2—C9—H9C109.5
C8—N1—C10121.42 (10)H9A—C9—H9C109.5
C2—N2—C3118.58 (11)H9B—C9—H9C109.5
C14—N3—C12112.86 (11)N1—C10—C11110.28 (10)
C14—N3—C11122.27 (11)N1—C10—H10A109.6
C12—N3—C11124.57 (12)C11—C10—H10A109.6
O1—C1—N1121.63 (12)N1—C10—H10B109.6
O1—C1—C2122.48 (12)C11—C10—H10B109.6
N1—C1—C2115.89 (11)H10A—C10—H10B108.1
N2—C2—C1123.75 (11)N3—C11—C10111.20 (11)
N2—C2—C9120.25 (12)N3—C11—H11A109.4
C1—C2—C9116.00 (12)C10—C11—H11A109.4
N2—C3—C4118.03 (12)N3—C11—H11B109.4
N2—C3—C8122.11 (12)C10—C11—H11B109.4
C4—C3—C8119.85 (12)H11A—C11—H11B108.0
C5—C4—C3120.55 (14)N3—C12—C13102.23 (13)
C5—C4—H4123.4 (11)N3—C12—H12A111.3
C3—C4—H4116.1 (11)C13—C12—H12A111.3
C4—C5—C6119.21 (14)N3—C12—H12B111.3
C4—C5—H7119.0 (11)C13—C12—H12B111.3
C6—C5—H7121.8 (11)H12A—C12—H12B109.2
C7—C6—C5121.64 (14)O2—C13—C12105.73 (13)
C7—C6—H6120.9 (11)O2—C13—H13A110.6
C5—C6—H6117.4 (11)C12—C13—H13A110.6
C6—C7—C8119.63 (14)O2—C13—H13B110.6
C6—C7—H5120.6 (10)C12—C13—H13B110.6
C8—C7—H5119.8 (10)H13A—C13—H13B108.7
N1—C8—C7122.83 (12)O3—C14—N3128.19 (14)
N1—C8—C3118.06 (11)O3—C14—O2122.27 (13)
C7—C8—C3119.10 (12)N3—C14—O2109.53 (12)
C2—C9—H9A109.5
D—H···AD—HH···AD···AD—H···A
C7—H5···O3i0.98 (2)2.54 (2)3.462 (2)157 (2)
C10—H10A···O3i0.972.433.348 (2)157
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C7—H5⋯O3i0.98 (2)2.54 (2)3.462 (2)157 (2)
C10—H10A⋯O3i0.972.433.348 (2)157

Symmetry code: (i) .

  5 in total

1.  Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.

Authors:  Soad A M El-Hawash; Abeer E Abdel Wahab
Journal:  Arch Pharm (Weinheim)       Date:  2006-08       Impact factor: 3.751

2.  Synthesis of certain substituted quinoxalines as antimicrobial agents (Part II).

Authors:  Mohga M Badran; Khaled A M Abouzid; M H M Hussein
Journal:  Arch Pharm Res       Date:  2003-02       Impact factor: 4.946

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents.

Authors:  Giovambattista De Sarro; Guido Ferreri; Pietro Gareri; Emilio Russo; Angela De Sarro; Rosaria Gitto; Alba Chimirri
Journal:  Pharmacol Biochem Behav       Date:  2003-02       Impact factor: 3.533

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total
  3 in total

1.  1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.

Authors:  Younes Ouzidan; Youssef Kandri Rodi; Frank R Fronczek; Ramaiyer Venkatraman; Lahcen El Ammari; El Mokhtar Essassi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-12

2.  3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.

Authors:  Caleb Anothane Ahoya; Rachid Bouhfid; Ballo Daouda; El Mokhtar Essassi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-10

3.  3-[2-(3-Phenyl-2-oxo-1,2-di-hydro-quin-oxalin-1-yl)eth-yl]-1,3-oxazolidin-2-one.

Authors:  Ballo Daouda; Mouhamadou Lamine Doumbia; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.